Company profile · free preview
BioCryst Pharmaceuticals
BCRX · Updated 10/24/2026
Revenue
—
Fiscal 2025
Net income
$263.9M
Fiscal 2025
Free cash flow
—
Fiscal 2025
Net cash / (debt)
—
Fiscal 2025
Five-year financials
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | $263.9M | (88.9M) | (226.5M) | (247.1M) | (184.1M) |
| Diluted EPS | — | — | — | — | — |
| Operating cash flow | $347.4M | (52.0M) | (95.1M) | (161.8M) | (142.2M) |
| Free cash flow | — | — | — | — | — |
| Cash | $89.7M | $104.7M | $110.6M | $304.8M | $504.4M |
| Total debt | — | — | — | — | — |
Where the cash went
Cumulative, fiscal 2021–2025, straight from the reported cash-flow statements.
Reinvested in capex
—
of operating cash flow
Returned to owners
—
of free cash flow (buybacks + dividends)
Diluted share count
—
change 2021–2025
| Operating cash flow | ($103.8M) |
| Capital expenditure | — |
| Free cash flow | — |
| Share buybacks | — |
| Dividends paid | — |
| Acquisitions (net) | — |
| Net debt issued / (repaid) | — |
| Stock-based compensation (non-cash) | — |
"—" means a year didn't report that line, so no total is shown rather than an estimate.
SEC filings
No filings stored yet.
Ask anything about BioCryst Pharmaceuticals's filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching freeMore companies
TEM TEMServiceNow, Inc. NOWNetflix, Inc. NFLXGH GHMDT MDTLMT LMTNBIS NBISSE SEMeta Platforms, Inc. METASpace Exploration Technologies Corp. SPCXMaxLinear, Inc. MXLWalmart Inc. WMTNVIDIA Corporation NVDAAmazon.com, Inc. AMZNMSTR MSTRChipotle Mexican Grill, Inc. CMGALM ALMBHP Group BHPLLY LLYCoreWeave, Inc. Class A Common Stock CRWVSalesforce, Inc. CRMRingCentral, Inc. RNGPalo Alto Networks, Inc. PANWPalantir Technologies Inc. PLTR